by Gerhard Fasol (31 October 2019)
Asahi Kasei Medical announced the acquisition of Austrian contract research firm ViruSure Forschung und Entwicklung GmbH based in Vienna (Austria).
ViruSure Forschung und Entwicklung GmbH
- Operations Director: Dr Andrew C Bailey,
- Finance and Administration Director: Dr Alexander Vodopivec
- Team members: approx 45 (as of Sept 2018)
- Investors: PP Capital AG
- http://www.virusure.com
Asahi Kasei Medical KK (旭化成メディカル株式会社)
- Founded July 24, 1974
- 100% subsidiary of Asahi Kasei KK
- Employees: 2040 (as of end March 2019)
- http://www.asahi-kasei.co.jp/medical/en/
- http://www.ak-bio.com/
Business divisions
- Dialysis: global leader driving progress in dialysis therapy
- Therapeutic Aphaeresis: making therapeutic aphaeresis available worldwide to expand treatment options and possibilities
- Blood transfusion: reducing blood transfusion risk and heightening trust in healthcare
- Bio-processes: expanding availability of high-quality drugs by enhancing safety in biopharmaceutical production
Copyright 2019 Eurotechnology Japan KK. All Rights Reserved.
Leave a Reply